Therapy News and Research

RSS

Implantable device revolutionizes thyroid management

A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time.

3 Oct 2024

Scientists overcome major challenge in gene therapy and drug delivery

Imagine trying to poke a hole in the yolk of a raw egg without breaking the egg white. It sounds impossible, but researchers at the University of California San Diego have developed a technology that performs a similarly delicate task in living cells. They created an array of nanopillars that can breach the nucleus of a cell - the compartment that houses our DNA - without damaging the cell's outer membrane.

3 Oct 2024

Primary care settings failing to address women's hot flashes

Timely identification and treatment of bothersome hot flashes have the potential to improve the lives of many women and save employers countless days of related absenteeism and lost work productivity. Yet, a new study finds that such symptoms are often not documented in electronic health records (EHRs) or not adequately addressed during primary care visits.

3 Oct 2024

New study could lead to a more potent treatment option for multiple sclerosis

Multiple Sclerosis (MS) is a long-term disease where the immune system mistakenly attacks the protective layer around nerve cells, known as the myelin sheath.

2 Oct 2024

Online insomnia treatment brings relief to overburdened caregivers

Providing care for a family member with a disabling illness can be a demanding job that leaves many people unable to sleep, but an online insomnia treatment developed at the University of Virginia School of Medicine can help, new research shows.

2 Oct 2024

Postmenopausal hormone therapy use declines amidst risk-benefit concerns

A study reveals a sharp decline in menopausal hormone therapy use among U.S. women, highlighting disparities across racial and ethnic groups over two decades.

2 Oct 2024

Epigenetic hallmarks of cancer unveiled in new research

Cancer mortality has just surpassed cardiovascular disease for the first time ever and one in two men, and one in three women, will be diagnosed with some form of the disease in the US, according to the NIH.

1 Oct 2024

Future directions and challenges in harnessing NK cells against Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles

1 Oct 2024

The role of FOXM1 and PD-L1 in malignant peripheral nerve sheath tumor resistance

A new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, "Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors."

1 Oct 2024

Umbilical cord blood transplants improve cancer survival rates across all races

Patients who receive umbilical cord blood transplants for blood cancers now live equally long regardless of their race, new research from UVA Cancer Center shows.

1 Oct 2024

Novel lipid nanoparticles enhance tissue-specific drug delivery

Penn Engineers have discovered a novel means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, presaging a new era in personalized medicine and gene therapy.

1 Oct 2024

Interdisciplinary project aims to revolutionize health care data integration

Health care is more than doctor visits; it's a team effort. But most artificial intelligence-driven technologies built on patient data use only the information provided by physicians, omitting crucial input from nurses and rehabilitation therapists.

1 Oct 2024

Unlocking the secrets of analytical services: An insider interview with colman byrne

In this interview, News-Medical talks to Mr. Byrne about the crucial role of analytical services.

From DSI, a PLG Company 1 Oct 2024

New mechanism uncovered behind immune decline after tuberculosis treatment

Researchers at Baylor College of Medicine and collaborating institutions have discovered a mechanism that drives the long-term decline in immune response that is observed after tuberculosis (TB) has been successfully treated.

1 Oct 2024

Iron retention in skin linked to psoriasis: Could hepcidin be the missing piece in treatment?

This study reveals hepcidin's significant role in psoriasis, linking iron retention to inflammation and keratinocyte growth, suggesting new therapeutic targets.

1 Oct 2024

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Cyto-Mine Chroma enhances single-cell analysis with advanced multiplexing and assay flexibility, optimizing functional screening workflows for researchers.

From Fluidic Sciences and Sphere Bio 1 Oct 2024

High levels of microplastics found in prostate tumors, possibly linked to take-out food

Researchers discovered microplastics in both tumor and para-tumor prostate tissues, with higher concentrations found in tumor samples, raising concerns about their potential role in cancer development.

1 Oct 2024

Traditional Chinese medicine shows potential in cancer treatment

Cancer, a pervasive global health concern, remains a leading cause of mortality worldwide. Current cancer treatment modalities encompass surgery, radiotherapy, chemotherapy, immunotherapy, and targeted therapy, all of which have significantly contributed to improving patient survival.

1 Oct 2024

New technique offers real-time glioblastoma monitoring

A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time.

1 Oct 2024

Study reveals harmful effects of conversion therapy on LGBTQ+ people

People identifying as LGBTQ+ who have undergone conversion practice – commonly known as conversion therapy – are more likely to experience poor mental health, according to a study published in The Lancet Psychiatry journal.

1 Oct 2024